R. E. Schopf

1.5k total citations
54 papers, 1.2k citations indexed

About

R. E. Schopf is a scholar working on Immunology, Physiology and Dermatology. According to data from OpenAlex, R. E. Schopf has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 15 papers in Physiology and 9 papers in Dermatology. Recurrent topics in R. E. Schopf's work include Psoriasis: Treatment and Pathogenesis (18 papers), Asthma and respiratory diseases (9 papers) and Dermatology and Skin Diseases (6 papers). R. E. Schopf is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (18 papers), Asthma and respiratory diseases (9 papers) and Dermatology and Skin Diseases (6 papers). R. E. Schopf collaborates with scholars based in Germany, Austria and Switzerland. R. E. Schopf's co-authors include Konrad Bork, E.‐M. Lemmel, W. Kreuz, Jürgen Knop, B. Morsches, Otto Scheiner, Diamant Thaçi, Peter Altmeyer, Peter Rich and J.‐P. Ortonne and has published in prestigious journals such as The Journal of Immunology, FEBS Letters and Journal of Investigative Dermatology.

In The Last Decade

R. E. Schopf

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Schopf Germany 17 656 284 251 203 193 54 1.2k
Federica Villanova United Kingdom 12 1.1k 1.7× 405 1.4× 214 0.9× 93 0.5× 183 0.9× 14 1.6k
Anne Black United Kingdom 22 255 0.4× 214 0.8× 719 2.9× 387 1.9× 155 0.8× 47 1.4k
W. M. Howell United Kingdom 19 351 0.5× 82 0.3× 96 0.4× 61 0.3× 89 0.5× 47 1.2k
Elham Farhadi Iran 19 358 0.5× 117 0.4× 352 1.4× 38 0.2× 123 0.6× 95 1.1k
Megumi Kishimoto Japan 15 668 1.0× 386 1.4× 126 0.5× 27 0.1× 56 0.3× 38 1.1k
Stefan Jenisch Germany 14 1.6k 2.5× 674 2.4× 345 1.4× 33 0.2× 192 1.0× 34 2.0k
Αthanasios Mavropoulos Greece 17 518 0.8× 115 0.4× 191 0.8× 48 0.2× 64 0.3× 40 1.0k
Jaehwan Kim United States 15 689 1.1× 409 1.4× 97 0.4× 69 0.3× 31 0.2× 28 1.1k
Barbara Maria Colombo Italy 17 389 0.6× 69 0.2× 331 1.3× 35 0.2× 78 0.4× 35 979
Roberto Bullani Switzerland 10 307 0.5× 255 0.9× 386 1.5× 29 0.1× 103 0.5× 14 1.3k

Countries citing papers authored by R. E. Schopf

Since Specialization
Citations

This map shows the geographic impact of R. E. Schopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Schopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Schopf more than expected).

Fields of papers citing papers by R. E. Schopf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Schopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Schopf. The network helps show where R. E. Schopf may publish in the future.

Co-authorship network of co-authors of R. E. Schopf

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Schopf. A scholar is included among the top collaborators of R. E. Schopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Schopf. R. E. Schopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schopf, R. E.. (2025). 0285 Psoriasis treatment with adalimumab leading to multiple sclerosis. Journal of Investigative Dermatology. 145(8). S49–S49.
2.
3.
Schopf, R. E., et al.. (2012). Unklare akrale Nekrosen an den Fingern. Der Hautarzt. 64(2). 114–116.
4.
Mrowietz, Ulrich, Peter Altmeyer, Thomas Bieber, et al.. (2007). Treatment of psoriasis with fumaric acid esters (Fumaderm®). JDDG Journal der Deutschen Dermatologischen Gesellschaft. 5(8). 716–717. 61 indexed citations
5.
Witkamp, Leonard, I.M. Zonneveld, R. E. Schopf, et al.. (2006). Efficacy and tolerability of multiple-dose SDZ IMM 125 in patients with severe psoriasis. British Journal of Dermatology. 133(1). 95–103. 5 indexed citations
6.
Schopf, R. E., et al.. (2002). A Highly Decreased Binding of Cyclic Adenosine Monophosphate to Protein Kinase A in Erythrocyte Membranes is Specific for Active Psoriasis. Journal of Investigative Dermatology. 119(1). 160–165. 3 indexed citations
7.
Schopf, R. E., et al.. (2002). Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab. Journal of the American Academy of Dermatology. 46(6). 886–891. 81 indexed citations
8.
D’Aniello, Salvatore, et al.. (2000). Rapid identification of Mycobacterium marinum by comparative 16S-rRNA-gene analysis in five cases of progredient cutaneous infections. European Journal of Dermatology. 7(4). 295–299. 4 indexed citations
9.
Bork, Konrad, et al.. (2000). Asphyxiation by Laryngeal Edema in Patients With Hereditary Angioedema. Mayo Clinic Proceedings. 75(4). 349–354. 196 indexed citations
10.
11.
12.
Mahrle, G., Hans‐Joachim Schulze, Matthias Bräutigam, et al.. (1996). Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study. British Journal of Dermatology. 135(5). 752–757. 33 indexed citations
13.
Dobmeyer, Jürgen, Thomas S. Dobmeyer, & R. E. Schopf. (1995). Importance of HLA-DR+ and CD1a+ Epidermal Cells for Cytokine Production in Psoriasis. Advances in experimental medicine and biology. 378. 539–541. 3 indexed citations
14.
Schopf, R. E., Jürgen Dobmeyer, Thomas S. Dobmeyer, & B. Morsches. (1993). Soluble CD14 Monocyte Antigen in Suction Blister Fluid and Serum of Patients with Psoriasis. Dermatology. 186(1). 45–49. 18 indexed citations
15.
Schopf, R. E., et al.. (1993). Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. British Journal of Dermatology. 128(1). 34–37. 42 indexed citations
16.
Schopf, R. E., H. Wéber, & B. Morsches. (1993). Enhanced procoagulant acticity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis. Archives of Dermatological Research. 285(5). 305–309. 2 indexed citations
17.
Bell, Mary, et al.. (1992). Light Exposure of the Lower Leg as a Pathogenetic Factor in the Occurrence of Malignant Melanoma. Dermatology. 185(4). 257–261. 14 indexed citations
18.
Schopf, R. E., et al.. (1992). Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis. Archives of Dermatological Research. 284(4). 227–231. 10 indexed citations
19.
Müller‐Quernheim, Joachim, et al.. (1987). A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis. Journal of Molecular Medicine. 65(19). 893–897. 9 indexed citations
20.
Schopf, R. E., et al.. (1987). Impaired function of numerically augmented Fc-receptors on granulocytes in a HLA B8+ patient with palmoplantar pustulosis. Archives of Dermatological Research. 279(7). 444–448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Villanova Breakdown of academic impact, for papers by Anne Black Breakdown of academic impact, for papers by W. M. Howell Breakdown of academic impact, for papers by Elham Farhadi Breakdown of academic impact, for papers by Megumi Kishimoto Breakdown of academic impact, for papers by Stefan Jenisch Breakdown of academic impact, for papers by Αthanasios Mavropoulos Breakdown of academic impact, for papers by Jaehwan Kim Breakdown of academic impact, for papers by Barbara Maria Colombo Breakdown of academic impact, for papers by Roberto Bullani
Rankless by CCL
2026